Encision Reports Second Fiscal Quarter Results
29 Outubro 2007 - 8:52AM
PR Newswire (US)
BOULDER, Colo., Oct. 29 /PRNewswire-FirstCall/ -- Encision Inc.
(AMEX:ECI), a medical device company owning patented surgical
technology that is emerging as a standard of care in
minimally-invasive surgery, reported its financial results for its
second fiscal quarter ended September 30, 2007. Net sales for the
second quarter of fiscal year 2008, ended September 30, 2007,
totaled $3.1 million, representing a 17% increase over net sales of
$2.65 million for the prior fiscal year's second quarter. The
Company recorded net income of $8 thousand or $.00 per basic share
for the second quarter of fiscal year 2008 compared to net income
of $32 thousand or $.01 per basic share for the second quarter of
fiscal year 2007. Gross profit margin for the second quarter of
fiscal year 2008 was 62% as compared to 64% for the second quarter
of fiscal year 2007. Gross profit margin for the second quarter of
fiscal year 2007 included an approximately 1.5% increase in gross
profit margin that was attributed to a decrease in accrued
liabilities related to warranty claims. Net sales for the first six
months of fiscal year 2008, ended September 30, 2007, totaled $5.75
million, representing a 6% increase over net sales of $5.4 million
for the prior fiscal year's first six months. The Company recorded
a net loss of $288 thousand or $.04 per share for the first six
months of fiscal year 2008 compared to net income of $136 thousand
or $.02 per share for the first six months of fiscal year 2007.
Gross profit margin for the first six months of fiscal year 2008
was 62% as compared to 63% for the first six months of fiscal year
2007. "We regained our traction in the second quarter with our
first three consecutive months of sales that exceeded a million
dollars a month," said Jack Serino, President and CEO of Encision
Inc. "Although relatively pleased with a 17% sales growth rate, we
will persistently pursue an even higher top-line growth." Encision
Inc. designs, develops, manufactures and markets innovative
surgical devices that allow surgeons to optimize technique and
patient safety during a broad range of surgical procedures. Based
in Boulder, Colorado, the Company pioneered the development of
patented AEM(R) Laparoscopic Instruments to improve electrosurgery
and reduce the chance for patient injury in minimally invasive
surgery. In accordance with the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995, the Company notes
that statements in this press release and elsewhere that look
forward in time, which include everything other than historical
information, involve risks and uncertainties that may cause actual
results to differ materially from those indicated by the
forward-looking statements. Factors that could cause the Company's
actual results to differ materially include, among others, its
ability to increase net sales through the Company's distribution
channels, insufficient quantity of new account conversions,
insufficient cash to fund operations, scale up production to meet
delivery obligations, delay in developing new products and
receiving FDA approval for such new products and other factors
discussed in the Company's filings with the Securities and Exchange
Commission. CONTACT: Marcia McHaffie, Encision Inc., 303-444-2600,
ENCISION INC. Condensed Statements of Operations (Amounts in
thousands, except per share information) (Unaudited) (Unaudited)
Three Months Ended Six Months Ended September 30, September 30,
September 30, September 30, 2007 2006 2007 2006 Net sales $3,092
$2,652 $5,752 $5,406 Cost of sales 1,166 953 2,198 2,001 Gross
profit 1,926 1,699 3,554 3,405 Operating expenses 1,920 1,687 3,837
3,296 Operating income (loss) 6 12 (283) 109 Other income (expense)
2 20 (5) 27 Net income (loss) $8 $32 $(288) $136 Basic net income
(loss) per share $0.00 $0.01 $(0.04) $0.02 ENCISION INC. Condensed
Balance Sheets (Amounts in thousands) (Unaudited) September 30,
(Audited) 2007 March 31, 2007 Cash and cash equivalents $59 $436
Current assets 3,502 3,637 Total assets 4,503 4,388 Current
liabilities 1,746 1,464 Shareholders' equity 2,757 2,923 Total
liabilities and shareholders' equity $4,503 $4,388 DATASOURCE:
Encision Inc. CONTACT: Marcia McHaffie of Encision Inc.,
+1-303-444-2600, Web site: http://www.encision.com/
Copyright
Encision (AMEX:ECI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Encision (AMEX:ECI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024